简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
摘要:Here's how Allergan went from its start as a sleepy but beloved company out of Southern California in the 1950s to an acquisition target for AbbVie.
AbbVie is acquiring Botox-maker Allergan in a $63 billion deal, the companies said Tuesday.
Allergan has had a long history dating back to the 1940s. Over the years it's gone through major acquisitions, including some that have fallen through.
Visit Business Insider's homepage for more stories.
Allergan, the pharmaceutical company best known for making Botox, on Tuesday agreed to be acquired by AbbVie in a $63 billion deal.
Investors had been unhappy with Allergan's stock performance over the last year, and some have been vocal in calling for change.
Here's how the company went from its start as a small but beloved company out of Southern California in the 1950s to the latest takeover target.
This article was initially published in June 2018 and has been updated.
免責聲明:
本文觀點僅代表作者個人觀點,不構成本平台的投資建議,本平台不對文章信息準確性、完整性和及時性作出任何保證,亦不對因使用或信賴文章信息引發的任何損失承擔責任